UnitedHealth Group Incorporated
Bear Case (25th pct.)
-52.6% vs price
Base Case (Median)
-43.5% vs price
Bull Case (75th pct.)
-22.1% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $155.10 | -62.6% | High (40%) |
| PE Comparable | $346.05 | -16.5% | Medium (25%) |
| Graham Number | $190.22 | -54.1% | Medium (40%) |
| EV/EBITDA | $253.41 | -38.8% | Medium (20%) |
| EV/FCF | $519.05 | 25.3% | Medium (20%) |
| Earnings Power Value | $214.47 | -48.2% | Medium (50%) |
Based on 6 out of 8 methods, UNH appears overvalued at the current price of $414.40. The base case fair value of $233.94 implies 43.5% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.